Atlas Trials

A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs

Clinical trial NCT07069569 · RECRUITING

Trial details

NCT number
NCT07069569
Sponsor
Ausper Biopharma Co., Ltd.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2025-06-08
Primary completion
2027-07-15
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.